The Department of Health and Human Service is pulling millions of dollars in funding for a human bird flu vaccine developed by Covid vaccine-maker Moderna.
Before President Donald Trump took office for his second term, the Biden administration had awarded $766 million to the Massachusetts-based drugmaker. They invested $176 million last summer, and tacked on another $590 million in January.
